Form 8-K - Current report:
SEC Accession No. 0001564590-21-040825
Filing Date
2021-08-04
Accepted
2021-08-04 16:15:40
Documents
13
Period of Report
2021-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acad-8k_20210804.htm   iXBRL 8-K 36627
2 EX-99.1 acad-ex991_6.htm EX-99.1 288186
  Complete submission text file 0001564590-21-040825.txt   469229

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acad-20210804.xsd EX-101.SCH 5792
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20210804_lab.xml EX-101.LAB 19475
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20210804_pre.xml EX-101.PRE 11644
6 EXTRACTED XBRL INSTANCE DOCUMENT acad-8k_20210804_htm.xml XML 3563
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 211144206
SIC: 2834 Pharmaceutical Preparations